Related references
Note: Only part of the references are listed.Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
Tim Palmer et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
Melanie Drolet et al.
LANCET (2019)
Impact of HPV vaccination on outcome of cervical cytology screening in Denmark-A register-based cohort study
Lise Holst Thamsborg et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Contraceptive non-use and emergency contraceptive use at first sexual intercourse among nearly 12 000 Scandinavian women
Sonia Guleria et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2017)
Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates
Kirsten Rozemeijer et al.
CANCER CAUSES & CONTROL (2016)
Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study
Eva Herweijer et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark
Matejka Rebolj et al.
BRITISH JOURNAL OF CANCER (2015)
Impact of technology on cytology outcome in cervical cancer screening of young and older women
J. Rask et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Outcomes in cervical screening using various cytology technologies: What's age got to do with it?
Sidsel S. Barken et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2013)
Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)
Catherine H. Mercer et al.
LANCET (2013)
Introduction of human papillomavirus vaccination in Nordic countries
Bente Braad Sander et al.
VACCINE (2012)
Women's sexual behavior. Population-based study among 65 000 women from four Nordic countries before introduction of human papillomavirus vaccination
Kirsten Egebjerg Jensen et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2011)
Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
Nubia Munoz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Suzanne M. Garland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cervical cancer screening in Denmark
J Bigaard et al.
EUROPEAN JOURNAL OF CANCER (2000)
Share Paper
